surmount 2 tirzepatide once weekly for the treatment of obesity in people with type diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial The SURMOUNT-MAINTAIN trial will help

I soon learned that it was a great deal

The reports of increased residual gastric content after long-term treatment with GLP-1 analogues emphasize that the effect on gastric emptying is sustained, even though that it does normally not pose a risk for postoperative respiratory complications [20]

GLP-1 and GIP both participate in incretin biology, while glucagon receptor activation may influence energy expenditure, fat oxidation, and liver metabolism

Thats because as far as I can see, its not being promoted by any companies that work with medical doctors. Initial reactions from users on TikTok are that people really like it, is all that aesthetic physician Dr Munir Somji will say

The activation of TGR5 triggers the production of intracellular cAMP and secondary active the mitogen activated protein kinase signaling pathway to perform different functions in various organs